Aicardi-Goutieres syndrome

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
NRTI 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Transposon Therapeutics Inc. Commercial
    CENSAVUDINE
    2024-511176-32-00 2 countries 2023 n=52
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Transposon Therapeutics Inc. Commercial 1 Phase II 0
New trials by year
2023
1
← All indication landscapes